Caliper's Q1 Revenues Jump 25 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Caliper Life Sciences today reported that its first-quarter revenues increased 25 percent as sales of its imaging and LabChip products returned strong double-digit gains.

The Hopkinton, Mass.-based firm brought in total revenues of $35.8 million for the three-month period ended March 31, compared to $28.7 million for the first quarter of 2010. Its revenues were driven by sales of its imaging and LabChip products, while its automation business declined.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.